AAAAAA

   
Results: 1-12 |
Results: 12

Authors: DECREMOUX H BEKRADDA M MONNET I SOULIE P SALTIEL S MISSET JL FANDI A BENSMAINE MA CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 474-474

Authors: DECREMOUX H BEKRADDA M MONNET I SOULIE P SALTIEL S MISSET JL FANDI A BENSMAINE MA CVITKOVIC E
Citation: H. Decremoux et al., UPDATE OF THE OXALIPLATIN (L-OHP) NAVELBINE (NVB) PHASE I/II MULTICENTRIC TRIAL IN PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)/, Annals of oncology, 9, 1998, pp. 446-446

Authors: BEKRADDA M CHATELUT E CVITKOVIC E SOULIE P CANAL P MISSET JL DUPONTANDRE G BENSMAINE MA BUGAT R
Citation: M. Bekradda et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS OF THE CARBOPLATIN (CBDCA)OXALIPLATIN (L-OHP) COMBINATION IN PATIENTS (PTS) WITH ADVANCED MALIGNANCIES - PRELIMINARY-RESULTS OF AN ONGOING PHASE-I TRIAL/, Annals of oncology, 9, 1998, pp. 447-447

Authors: DUCREUX M LOUVET C BEKRADDA M CVITKOVIC E
Citation: M. Ducreux et al., OXALIPLATIN FOR THE TREATMENT OF ADVANCED COLORECTAL-CANCER - FUTURE-DIRECTIONS, Seminars in oncology, 25(2), 1998, pp. 47-53

Authors: CULINE S THEODORE C BEKRADDA M FARHAT F TERRIERLACOMBE MJ DROZ JP
Citation: S. Culine et al., EXPERIENCE WITH BLEOMYCIN, ETOPOSIDE, CISPLATIN (BEP) AND ALTERNATINGCISPLATIN, CYCLOPHOSPHAMIDE, DOXORUBICIN (CISCA(II)) VINBLASTINE, BLEOMYCIN (VBIV) REGIMENS OF CHEMOTHERAPY IN POOR-RISK NONSEMINOMATOUS GERM-CELL TUMORS, American journal of clinical oncology, 20(2), 1997, pp. 184-188

Authors: CULINE S THEODORE C FARHAT F BEKRADDA M TERRIERLACOMBE MJ DROZ JP
Citation: S. Culine et al., CISPLATIN-BASED CHEMOTHERAPY AFTER RETROPERITONEAL LYMPH-NODE DISSECTION IN PATIENTS WITH PATHOLOGICAL STAGE-II NONSEMINOMATOUS GERM-CELL TUMORS, Journal of surgical oncology, 61(3), 1996, pp. 195-198

Authors: FARHAT F CULINE S THEODORE C BEKRADDA M TERRIERLACOMBE MJ DROZ JP
Citation: F. Farhat et al., CISPLATIN AND IFOSFAMIDE WITH EITHER VINBLASTINE OR ETOPOSIDE AS SALVAGE THERAPY FOR REFRACTORY OR RELAPSING GERM-CELL TUMOR PATIENTS - THEINSTITUT-GUSTAVE-ROUSSY EXPERIENCE, Cancer, 77(6), 1996, pp. 1193-1197

Authors: CULINE S BEKRADDA M TERRIERLACOMBE MJ DROZ JP
Citation: S. Culine et al., TREATMENT OF SARCOMATOID RENAL-CELL CARCINOMA - IS THERE A ROLE FOR CHEMOTHERAPY, European urology, 27(2), 1995, pp. 138-141

Authors: MOUNEDJIBOUDIAF L CULINE S DEVOLDERE G TERRIERLACOMBE MJ KATTAN J CAZIER A FARHAT F BEKRADDA M DROZ JP
Citation: L. Mounedjiboudiaf et al., PRIMARY HIGH-GRADE NON-HODGKIN-LYMPHOMA O F THE PROSTATE WITH A B-CELL ORIGIN - A CASE-REPORT AND REVIEW OF THE LITERATURE, Bulletin du cancer, 81(4), 1994, pp. 334-337

Authors: FARHAT F KATTAN J CULINE S THEODORE C TERRIERLACOMBE MJ GENIN J MOUNEDJIBOUDIAF L BEKRADDA M DROZ JP
Citation: F. Farhat et al., LIPOSARCOMA OF THE SPERMATIC CORD - A CAS E-REPORT AND REVIEW OF THE LITERATURE, Bulletin du cancer, 81(3), 1994, pp. 223-225

Authors: ABS L KATTAN J CULINE S BEKRADDA M FARHAT F DROZ JP
Citation: L. Abs et al., PIPERACILLIN PLUS SULBACTAM POTENTIALLY A SSOCIATED TO VANCOMYCIN ANTIMICROBIAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS TREATED FOR SOLD TUMORS, Bulletin du cancer, 81(10), 1994, pp. 871-876

Authors: FARHAT F KATTAN J CULINE S BEKRADDA M DROZ JP
Citation: F. Farhat et al., 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATINU M (FAP REGIMEN) EFFICACY INMETASTATIC ADENOID CYSTIC CARCINOMA - A CASE-REPORT AND REVIEW OF THELITERATURE, Bulletin du cancer, 81(1), 1994, pp. 47-50
Risultati: 1-12 |